Forum Health

Forum Health

Forum Health was launched around Hagerman’s conviction that conventional medicine underdelivers on chronic disease. The organization functions as a direct operating rollup in the functional and integrative medicine space, purchasing private clinics and installing shared clinical, operational, and product infrastructure. Its geographic footprint spans 25+ locations clustered across the United States, with virtual care extending its reach to most states. The firm’s service stack covers a deliberately wide range of chronic and wellness conditions: hormonal health, weight loss and metabolism, gut disorders, Lyme disease, sexual health, and longevity protocols. Revenue streams blend direct patient pay for clinical consultations alongside the sale of nutraceutical supplements, IV therapies, and compounded pharmaceuticals. Forum Health’s own dispensing pharmacy, Strive Pharmacy based in Gilbert, Arizona, provides fulfillment for hormone replacement and GLP-1/semaglutide injections prescribed through the network, capturing margin that would otherwise go to third parties. Hagerman runs Forum Health Enterprises as the parent entity, which encompasses the clinic network, the nutraceutical arm Inwell Biosciences, and the practice-management platform Power2Practice — each serving as both an internal capability and a potential standalone commercial product. President Adam Puttkammer, with a leadership background in healthcare operations and software, oversees the day-to-day integration of these units. The firm promotes a provider count of over 90 clinicians, including Lyme disease specialist and Chief of Staff Dr. Andrew Petersen. There is no publicly disclosed fund vehicle or outside limited partners, indicating the capital likely comes from Hagerman’s SkyPoint Ventures and other principals. Unlike a standard private equity platform that strips costs, Forum Health’s architecture adds a captive pharmacy and proprietary supplement line vertically into the acquired practice models. That structural decision makes clinical protocols, pharmacy fulfillment, and product revenue interdependent — each patient visit can trigger margin at the clinic level and at the distribution arm.